AWRE Stock Charts

Quarterly

Annual

Unit: USD	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31

cash flows from operating activities:
net income	-982,000	-4,239,000	1,145,000	-2,652,000	-1,568,000	-1,757,000	2,598,000	-1,288,000	-1,279,000	-1,255,000	-1,579,000	-1,542,000	-1,448,000	-1,636,000	-1,777,000	-3,141,000	-1,060,000	-7,479,000	-151,000	-938,000	228,000	639,000	1,277,000	-188,000	-495,000	-581,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	139,000	141,000	139,000	149,000	149,000	173,000	141,000	221,000	225,000	167,000	171,000	172,000	177,000	160,000	138,000	131,000	132,000		110,000	111,000	110,000	107,000	107,000	107,000	122,000	128,000
stock-based compensation	164,000	428,000	359,000	403,000	335,000	351,000	548,000	378,000	430,000	490,000	441,000	439,000	197,000	281,000	244,000	230,000	83,000	312,000	190,000	176,000	14,000	186,000	186,000	184,000	24,000	198,000
interest on note receivable			-31,000	-31,000	-31,000
non-cash lease expense	17,000	19,000	23,000	22,000	173,000
changes in assets and liabilities:
accounts receivable	-1,302,000	4,080,000	-2,733,000	-1,116,000	417,000	454,000	310,000	-64,000	-368,000	-561,000	-1,160,000	898,000	-587,000	-332,000	326,000	-458,000	548,000	963,000	-514,000	-1,025,000	99,000	3,349,000	-1,842,000	-1,252,000	124,000	3,216,000
unbilled receivables	-167,000	371,000	1,246,000	466,000	-325,000	598,000	-326,000	-255,000	-88,000	207,000	-406,000	-385,000	-253,000	-2,000	-209,000	1,207,000	90,000	940,000	-596,000	259,000	-639,000	-1,124,000	-613,000	-309,000	196,000
prepaid expenses and other current assets	-12,000	-154,000	-352,000	74,000	-181,000	370,000	-397,000	15,000	-394,000	154,000	-386,000	172,000	51,000	198,000	-360,000	75,000	-84,000	170,000	-192,000	274,000	-224,000	102,000	-162,000	100,000	-108,000	112,000
accounts payable	511,000	49,000	-364,000	-29,000	-15,000	-350,000	433,000	83,000	190,000	-320,000	299,000	-238,000	10,000	236,000	-26,000	69,000	28,000	-44,000	64,000	-6,000	47,000	-34,000	-4,000	-70,000	68,000	-366,000
accrued expenses	-675,000	59,000	759,000	106,000	-502,000	-408,000	-101,000	531,000	-650,000	-145,000			-229,000	-164,000	-174,000	693,000	80,000	-159,000	26,000	15,000	-105,000	-366,000	319,000	85,000	-120,000	-88,000
deferred revenue	-104,000	-375,000	1,554,000	563,000	63,000	-74,000	274,000	233,000	-440,000	593,000	199,000	-596,000	-389,000	276,000	80,000	344,000	-220,000	-811,000	1,224,000	-92,000	-583,000	-16,000	694,000	25,000	-536,000	203,000
net cash from operating activities	-2,411,000	3,065,000	2,457,000	-2,214,000	-1,485,000	-481,000	-2,003,000	-177,000	-2,381,000	-1,016,000	-1,896,000	-851,000	-2,471,000	-1,084,000	-2,246,000	-1,395,000	-549,000	-69,000	-558,000	-1,267,000	-1,051,000	2,823,000	19,000	-1,379,000	-803,000	3,058,000
capex	0	0	0	0	-16,000	-586,000	-133,000	0	0	-6,000	0	0	0	-20,000	-112,000	-66,000	-286,000	-33,000	-9,000	-49,000	-20,000	-64,000	-8,000	-38,000	-96,000	-21,000
free cash flows	-2,411,000	3,065,000	2,457,000	-2,214,000	-1,501,000	-1,067,000	-2,136,000	-177,000	-2,381,000	-1,022,000	-1,896,000	-851,000	-2,471,000	-1,104,000	-2,358,000	-1,461,000	-835,000	-102,000	-567,000	-1,316,000	-1,071,000	2,759,000	11,000	-1,417,000	-899,000	3,037,000
cash flows from investing activities:
purchases of property and equipment		0	0	0	-16,000	-586,000	-133,000			-6,000	0			-20,000	-112,000	-66,000	-286,000	-33,000	-9,000	-49,000	-20,000	-64,000	-8,000	-38,000	-96,000	-21,000
purchase of marketable securities			-1,211,000	-5,165,000	-2,752,000
sale of marketable securities	6,724,000	1,250,000	1,250,000	2,250,000	1,250,000
net cash from investing activities	6,724,000	1,250,000	39,000	-2,915,000	-1,518,000	665,000	-10,142,000	-11,000	-2,500,000	-2,456,000	0			-2,450,000	-112,000	-66,000	-286,000	-33,000	-9,000	-49,000	-20,000	-64,000	-8,000	-38,000	-96,000	-21,000
cash flows from financing activities:
payments made for taxes of employees who surrendered shares related to unrestricted stock		-1,000	0	0	-15,000	-2,000				0	0	0	-54,000	-4,000	-39,000			0	-43,000	0	-49,000	0	-46,000	0	-61,000	0
repurchase of common stock		-39,000	-126,000	0	-341,000	-1,148,000	-161,000							-242,000	-235,000			-184,000	-342,000	-161,000	-78,000	-133,000	-123,000			-586,000
net cash from financing activities		4,000	-126,000	52,000	-356,000	-1,092,000	-182,000			138,000	1,000	24,000	-54,000	-219,000	-275,000	-445,000	-50,000	-163,000	-385,000	-139,000	-127,000	-110,000	-169,000	-110,000	-61,000	-554,000
increase in cash and cash equivalents	4,313,000
cash and cash equivalents, beginning of period	10,002,000		0	0	11,749,000		0	0	29,963,000		0	0	38,565,000		0	0	47,742,000		0	0	51,612,000		0	0	51,608,000
cash and cash equivalents, end of period	14,315,000		2,370,000	-5,077,000	8,390,000		-12,327,000	-98,000	25,082,000		-1,895,000	-848,000	36,040,000		-2,633,000	-1,906,000	46,857,000		-952,000	-1,455,000	50,414,000		-158,000	-1,527,000	50,648,000
supplemental disclosure: cash paid for income taxes			0
gain on sale of fixed assets						0
interest receivable						-31,000	-32,000	-31,000	-7,000
loss on write-off of note receivable
change in fair value of contingent acquisition payments
credit losses
increase from changes in assets and liabilities:
tax receivable		6,000	1,491,000
proceeds from sale of fixed assets						0
purchases of marketable securities						1,000
investment in note receivable						0	0	0	-2,500,000
proceeds from issuance of unrestricted stock
decrease in cash and cash equivalents		4,319,000	2,370,000	-5,077,000	-3,359,000	-908,000	-12,327,000	-98,000	-4,881,000	-3,334,000	-1,895,000	-848,000	-2,525,000	-3,753,000	-2,633,000	-1,906,000	-885,000		-952,000	-1,455,000	-1,198,000		-158,000	-1,527,000	-960,000
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
supplemental disclosure:
cash paid for income taxes																0	1,000	3,000	0			2,000	16,000	70,000	8,000	15,000
bad debt provision						123,000
change in fair value of contingent acquisition payment
proceeds from issuance of common stock			0				3,000			138,000				27,000	-1,000			21,000	0			23,000	0			19,000
bad debt recovery
deferred taxes
cash paid for acquisitions
long-term tax receivable														-219,000	-488,000	-545,000	-146,000
processed from issuance of common stock
deferred tax assets																		5,929,000	-595,000	-154,000	-9,000	28,000	24,000	-60,000	-92,000	246,000
cash paid for acquisition
accrued income taxes																				113,000	11,000	-48,000	33,000	-1,000	14,000	-10,000
payments made for taxes of employees who surrendered
shares related to unrestricted stock																	-50,000
depreciation
increase/(decrease) in cash and cash equivalents
amortization of discount on investments																										0
gain on sale of investments																										0
deferred tax expense on other comprehensive income
sales of investments																										0
proceeds from exercise of stock options
deferred tax benefit on other comprehensive income
reversal of reserve for uncertain tax positions
gain on sale of patent assets
deferred tax benefit (expense) on other comprehensive income
inventories
proceeds from sale of patent assets
purchase of other assets
excess tax benefits from stock-based compensation
amortization of premium (discount) on investments
(gain)/loss on sale of investments
payment of dividends
loss on disposal of property and equipment
receivable from patent arrangement
proceeds from sale of property and equipment
purchases of investments

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.